Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

In episode 579, Mike and James invite Nicholas Dugré back to the podcast to talk about the evidence around the benefits and harms of a new class of medications for the acute treatment of episodic migraines. Ubrogepant is an oral calcitonin gene-related peptide antagonist. In this case, amazing as it may sound, there are triple…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #40: Heart failure follow up

In this episode of In the Clinic, Mike and Jess invite back Dr. Dr. Emelie Braschi.  The team discusses Mr. Ramakanta, a 75 year old male with reduced ejection fraction…
Listen 0.5 credits available

In the Clinic Episode #39: Heart failure

In this episode of In the Clinic, Mike and Jess invite back Dr. Emelie Braschi. The team discusses Mr. Ramakanta, a 75 year old male recently discharged from the hospital…
Listen 0.5 credits available

In the Clinic Episode #38: Pediatric asthma exacerbation

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young.  The team discusses Brea Salter, a 4 year old female with a  two day history…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Dr. Nicholas Dugré

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Dr. Nicholas Dugré

Spearkers do not have any conflicts of interest to declare.